The often ensuing loss-of-heterozygosity (LOH) in the remaining functional wildtype allele during cancer development, frequently recapitulated in animal studies45,46, alludes to pro-survival advantages provided by p53 mutants. The gene discussed is TP53; the disease is cancer.